BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: ➤ Sign Up

« Back to Dashboard

Details for Patent: ➤ Sign Up

Title: Methods of treating tumors with compositions of catecholic butanes
Abstract:The invention relates to methods useful in the treatment of benign, premalignant and malignant solid tumors, especially those of the skin comprising methods for the administration of pharmacologically active compositions containing catecholic butanes. The invention also relates to methods of preventing the occurrence of tumors, and the use of catecholic butanes as a sunscreening agent. The preferred catecholic butane is nordihydroguaiaretic acid. The preferred methods of application of the compositions containing catecholic butanes are by topical application and intratumor injection.
Inventor(s): Neiss; Edward S. (Denver, CO), Allen; Larry M. (Golden, CO), Jordan; Russell T. (Fort Collins, CO)
Assignee: Block/Chemex, G.P. (Jersey City, NJ)
Filing Date:Apr 15, 1991
Application Number:07/685,609
Claims:1. A method for treating warts which comprises administering to a mammal in need of said treatment an effective amount of a composition comprising at least one catecholic butane of the formula: ##STR3## wherein R.sub.1 and R.sub.2 are independently H, lower alkyl, lower acyl, or alkylene provided that when R.sub.1 is H R.sub.2 is not H;

R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.10, R.sub.11, R.sub.12 and R.sub.13 are independently H or lower alkyl; and

R.sub.7, R.sub.8 and R.sub.9 are independently H, hydroxy, lower alkoxy, lower acyloxy, or any two adjacent groups together may be alkylene dioxy.

2. A method for treating warts comprising administering to a mammal in need of said treatment an effective amount of a composition comprising nordihydroguairetic acid.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Johnson and Johnson
US Army
Cantor Fitzgerald
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: